The mutant-to-wild-type allelic ratio and the presence of concomitant nucleophosmin (NPM1) mutations influence the prognosis of this subset of patients [7] defining different subclasses of FLT3 and/or NPM1-mutated leukemias. The gene discussed is FLT3; the disease is leukemia.